NEWS
- Cleavable & Non-Cleavable PEG Linkers for XDCs
- Antibody-drug Conjugates for HER2-Positive Gastric Cancer
- c-MET: A Novel Target for Anticancer Therapies
- Novel FRα-targeting Antibody-drug Conjugates (ADCs)
- Nectin-4-Directed Drugs for Solid Tumors
- Recent Advances In Hematology 2022: ADCs, Bispecific Antibodies, CAR-T Cells…
- Emerging Multiple Myeloma Therapies: mAbs, ADCs, CAR-T Cells & Bispecific Antibodies
- Claudin18.2 Targeted Therapies In Cancer
- FDA Approves Tivdak - First Tissue Factor (TF)-Targeted Antibody Conjugate Drug (ADC)
- Visit Us at PEGS Boston Summit 2023, Booth #212